Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.

NCT00766038 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00766038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00766038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized Controlled Trial of Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2008
Completion date
December 31, 2013
Enrollment
63 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury